Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Monocytic leukemia is a type of blood cancer that affects monocytes, a specific type of white blood cell. While comprehensive diagnosis typically involves multiple approaches including blood cell analysis and bone marrow examination, blood tests play a fundamental role in detecting abnormal patterns and supporting the diagnostic process.
This test measures lysozyme levels in the blood, which can become significantly elevated in monocytic leukemia. The excessive production of abnormal monocytes characteristic of this condition leads to increased lysozyme release, making this test valuable for supporting diagnosis and monitoring disease activity.
Blood tests are essential for identifying the characteristic changes that occur when monocytes become cancerous and multiply excessively. These tests can reveal elevated levels of certain substances produced by abnormal monocytes, helping healthcare providers assess disease presence and progression.
Elevated lysozyme levels may indicate the presence of monocytic leukemia, but results must always be interpreted alongside other clinical findings and tests. Your healthcare provider will consider these results as part of a comprehensive evaluation to determine the most appropriate next steps for diagnosis and treatment.
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment.